Shares of Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV – Get Free Report) traded up 88.1% during trading on Tuesday . The company traded as high as $0.65 and last traded at $0.59. 1,605 shares changed hands during mid-day trading, an increase of 25% from the average session volume of 1,281 shares. The stock had previously closed at $0.31.
Mosaic ImmunoEngineering Stock Up 88.1 %
The stock’s 50 day simple moving average is $0.44 and its two-hundred day simple moving average is $0.52.
Mosaic ImmunoEngineering (OTCMKTS:CPMV – Get Free Report) last issued its earnings results on Monday, April 15th. The company reported ($0.04) earnings per share (EPS) for the quarter.
About Mosaic ImmunoEngineering
Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.
See Also
- Five stocks we like better than Mosaic ImmunoEngineering
- What Are Dividend Challengers?
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Stock Dividend Cuts Happen Are You Ready?
- Hilton Demonstrates Asset Light is Right for Investors
- 5 Top Rated Dividend Stocks to Consider
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Mosaic ImmunoEngineering Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mosaic ImmunoEngineering and related companies with MarketBeat.com's FREE daily email newsletter.
